Skip to content

Debt-to-equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.8×+0.1×
Danaher logo
DanaherDHR
0.4×0.0×
Agilent Technologies logo
Agilent TechnologiesA
0.5×-0.1×
Illumina logo
IlluminaILMN
0.8×-0.1×
TEC
Bio-TechneTECH
0.1×-0.1×
Revvity logo
RevvityRVTY
0.5×+0.1×

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

Based on the most recent quarter.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's debt-to-equity?
Twist Bioscience Corporation (TWST) reported debt-to-equity of 0.2× in Q1 2026.
How has Twist Bioscience Corporation's debt-to-equity changed year-over-year?
Twist Bioscience Corporation's debt-to-equity increased by 12.5% year-over-year, from 0.2× to 0.2×.
What is the long-term trend for Twist Bioscience Corporation's debt-to-equity?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's debt-to-equity has grown at a 12.3% compound annual growth rate (CAGR), from 0.1× to 0.2×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.